Farmabiotec Magazine, in its issue no. 22 (2025), features 300K Solutions in its biotechnology innovation section, highlighting the company’s advances in biomarker stabilization technology. In

300K Solutions will participate in the BBMRI.it National Day, to be held on November 18th, 2025, at the University of Milano-Bicocca in Milan, Italy. We

300K Solutions will attend the XIX National Congress of Clinical Laboratory (LABCLIN 2025), to be held from November 12th to 14th in Valencia, Spain. You

Madrid, October 28, 2025 – 300K Solutions participated last Tuesday in the Public-Private Collaboration Forum in Healthcare, organized by Libertad Digital at the Institute of

300K Solutions will attend the III Jornadas de las Plataformas ISCIII de Apoyo a la I+D+I en Biomedicina y Ciencias de la Salud, to be held

300K Solutions attended the IBMS Congress 2025, held from September 22nd to 25th at the International Convention Centre in Birmingham, United Kingdom. This is the

300K Solutions was present at the 13th National Biobanking Symposium, held from September 22nd to 23rd in Berlin, Germany. This was our first time participating

We are excited to announce a new collaboration with the Center for Biomarker Research in Medicine (CBMed) in Graz, Austria! This validation study aims to

For the first time, 300K Solutions was present at Les 14èmes Rencontres toulousaines du Club 3C-R, held from June 3rd to 4th in Toulouse, France.

300K Solutions was present at the SLAS Europe 2025 Conference & Exhibition, held from May 20th to 22nd at the Congress Center Hamburg in Hamburg,

300K Solutions s was present at the ISBER 2025 Annual Meeting, held in Montreal, Canada, from May 12th to 16th. At our booth, we showcased

300K Solutions was present at the Europe Biobank Week Congress 2025, held from May 13th to 16th in Bologna, Italy. We were excited to showcase

At 300K Solutions , we have started a new validation study in collaboration with Fundación Instituto Valenciano de Oncología (IVO). The goal of this joint

Farmabiotec Magazine, in its issue no. 18 (2025), features 300K Solutions in its biotechnology innovation section. In the interview, Fernando Martín de Lara, CEO of

We had the pleasure of participating in the Advanced Therapies Meeting 2025. At the event, 300K Solutions demonstrated how we are standardizing biomarker stabilization at

300K Solutions  participated in the III BioMedLab Conference, held in Lisbon, alongside our distributor Enzifarma, supporting the dissemination of technical and scientific knowledge in the

We had the privilege of taking part in the X Liquid Biopsy Symposium, held on January 23–25, 2025 in Santiago de Compostela. This symposium brought